InvestorsHub Logo

jakedogman1

03/26/17 11:05 AM

#292497 RE: ku #292496

the science side is good... the mgmt side is not... the share price will not increase to its optimal level (one where the influence of red flags prevents participants from entering arena) until the issues that prevent the potential participants are removed... issues related to the BOD...


mgmt has the keys to unlocking this problem...

unfortunately mgmt's best economic alternative is to take the enormous fees and get more and more lottery tickets paid for by the shareholders... if you are on that team, why would you want change?

biopharm

03/26/17 11:23 AM

#292498 RE: ku #292496

"This stock is not going to go anywhere until the BPs decide it will go. "

I think you are wrong.....just ask those involved in PCI Parker Cancer Institute, including MSK ...which includes Dr Wolchok

BPs no longer rule the top labs

I bet BPs were pi$$.. ed when they found out about how 6 of the top cancer hospitals joined PCI

Sounds to me like if a BP does not bend, and make a nice offer...then what stops Sean Parker from making Peregrine Pharmaceuticals/ PS Targeting the cornerstone molecule / patent for them to build upon..

BPs should realize the way things were done have gone Fargo too deep and times are changing....and have changed for good.

JJ1223

03/26/17 12:38 PM

#292503 RE: ku #292496

This stock is not going to go anywhere until the BPs decide it will go.


BP's do not decide collectively. Only one has to decide that Bavi will be a competitive advantage. Dr. Wolchok might just be the one that convinces the crowd.